Plain-English translation of NCT07553273 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a small vibrating device called DigiVibe can reduce pain when patients receive corticosteroid injections in their arms. You'll receive two injections—one in each arm—as part of your regular medical care, but each arm will receive a different pain-relief method to compare which works best. The study wants to see if vibration, cooling spray, or both together help make the injection less painful.
Many patients find injections painful and stressful, and doctors are looking for simple, non-drug ways to make the experience more comfortable. This study will help determine whether this vibrating device is an effective tool to reduce needle pain during routine treatments.
You likely qualify if…
You likely don't qualify if…
You'll attend a single study visit lasting about 20 minutes. You'll receive two corticosteroid injections—one in each arm—as part of your regular medical care. Each arm will be randomly assigned to receive different pain management: one might get no pain relief, cooling spray, vibration from the DigiVibe device, or a combination. After each injection, you'll complete a short pain rating scale to describe how much it hurt. That's it—the study doesn't require follow-up visits beyond your regular care.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States